Predict your next investment

Sani-Tech West company logo
INDUSTRIAL | Manufacturing / Laboratory & Research Equipment Manufacturing
sani-techwest.com

See what CB Insights has to offer

Founded Year

1991

Stage

Acq - Fin | Alive

About Sani-Tech West

Sani-Tech West manufactures high purity liquid handling products for the pharmaceutical and biotech industries.

Sani-Tech West Headquarter Location

1020 Flynn Road

Camarillo, California, 93012,

United States

800-726-4835

Latest Sani-Tech West News

08:53 ET SaniSure Completes State-of-the-Art Extractables and Biocompatibility Testing For Multiple Product Lines

Sep 28, 2021

News provided by Share this article Share this article CAMARILLO, Calif., Sept. 28, 2021 /PRNewswire/ -- SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announces the completion of a comprehensive extractables and biocompatibility study for many key products commonly used in biopharma manufacturing and development. SaniSure contracted with The BioProcess Institute to conduct a thorough and independent extractables study for many products which were tested in accordance with USP <665> extractables protocols and USP Class VI and ISO 10993 (multiple parts) biocompatibility protocols. Extractables testing was conducted per USP <665> with three solvents (Ethanol/Water, Acid, Base), and 21-day and 70-day timeframes. The components were qualified based on the current USP <665> draft, which has strong alignment with BPOG's end-user best practices, with additional testing included to provide the best assessment of the materials' capabilities. To assess potential extractables based on their intended use, SaniSure's components were either pre-treated with gamma irradiation (at maximum dose), autoclaved (at 130°C), and/or aseptically welded (tubing), and then subjected to the extraction studies. The test protocols for biocompatibility included USP <87> and ISO 10993-05 for in vitro Cytotoxicity, and USP <88>, ISO 10993-06, -10, and -11 for in vivo testing. This major investment was essential to achieve SaniSure's goal of enabling customers to conduct advanced and quantitative risk analyses for a broad range of applications. "We understand that identifying extractable and leachable substances is extremely important to our biopharma customers," said Stefan Schlack, CCO of SaniSure. "When our customers are specifying our product-contact materials into their bio-process, it is critical to have state-of-the- art quantitative data to perform their risk assessments." The products have also undergone additional physical, chemical, and biological testing to support their use. All studies were conducted by licensed outside laboratories and meet the applicable requirements of CGLP, FDA CFR Part 58, European Pharmacopoeia, ISO, and other special test requirements. The following SaniSure products were included in the study: PharmaTainerTM PET and Polycarbonate (PC) Containers HDPE and PP Caps for PharmaTainerTM Cap2V8® Molded Bottle Closures Pharma-Clear® LH (Low Hysteresis) Platinum-Cured Silicone Tubing Pharma-Clear® R Braided-Silicone Hose (inner-tubing tested) SaniSure is a global leader in the design and manufacturing of single-use systems and components for drug and vaccine manufacturing and other biotech applications. With the consolidation of Cellon, Silicone Altimex, TBL Performance Plastics, and Sani-Tech West in to SaniSure, their resources, capabilities, and ability to create value for their customers is unmatched in the industry. Their core manufacturing capabilities include injection molding, injection-stretch blow molding, cleanroom assembly, tubing extrusion, fabrication, and many other proprietary technologies. They offer a wide range of single-use technology products including sterile single-use assemblies, PharmaTainerTM bottles and carboys, Mixed4SureTM mixing solutions, Cap2V8® bottle closures, Pharma-Clear® Silicone Tubing, Cellgyn® TPE tubing, aSURE® fittings and many more. SaniSure has a growing footprint of five manufacturing sites worldwide to provide customers with an unrivaled level of vertical integration and supply-chain security. Copy of the study: https://sanisure.com/get-report/ Visit our website: https://sanisure.com/

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Sani-Tech West Patents

Sani-Tech West has filed 3 patents.

The 3 most popular patent topics include:

  • Fluid dynamics
  • Laboratory equipment
  • Aerodynamics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/8/2021

9/7/2021

Fluid dynamics, Cooling technology, Heat exchangers, Laboratory equipment, Gas technologies

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/8/2021

00/00/0000

00/00/0000

Grant Date

9/7/2021

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Fluid dynamics, Cooling technology, Heat exchangers, Laboratory equipment, Gas technologies

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Sani-Tech West Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sani-Tech West Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.